PepTalk 2017
PepTalk 2017

Pipeline One Header

Cambridge Healthtech Institute’s Third Annual
Engineering Next-Generation Cancer Immunotherapies
New Science and Technologies for Protein Engineers and Discovery Scientists to Support Development of Novel Immunotherapeutics and Treatment Combinations
January 9-10, 2017 | Hilton San Diego Bayfront | San Diego, CA


A succession of strong clinical successes by antibody therapeutics against the mainstream checkpoint targets has spawned a surge of interest from across the industry in advancing novel immunotherapeutics and agents that perform well in treatment combinations. Cambridge Healthtech Institute’s Third Annual Engineering Next-Generation Cancer Immunotherapies meeting offers important updates on scientific strategies and technologies that will be used by protein engineers and discovery scientists to support the development of the next wave of highly efficacious cancer immunotherapies.

We invite presentation proposals on the following preliminary topics:

  • Discovery and engineering of agonist immunotherapies
  • Emerging immunotherapy targets and pathways
  • Engineering antibody isotype and fc receptor interactions in cancer immunotherapies
  • Engineering issues in the development of bispecific antibodies against immunotherapy targets
  • Mechanisms of action for immunomodulation of the tumor microenvironment
  • New understandings to enable the de novo design of protein immunotherapies
  • Next-generation strategies for targeting major checkpoint inhibitors
  • Optimizing the binding properties of antibodies against immunotherapy targets
  • Screening to measure the activation status of T cells
  • Translational challenges and solutions for immunotherapies

Please click here to submit a speaking proposal for review.

Deadline for submission: May 27, 2016

All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program. Please note that due to limited speaking slots, preference will be given to abstracts from those within pharmaceutical and biopharmaceutical companies, regulators and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For questions about the meeting, please contact:

Kent Simmons
Senior Conference Director
Cambridge Healthtech Institute
Phone: 207-869-9199
Email: ksimmons@healthtech.com

For partnering & sponsorship information, please contact:

Companies A-K
Jason Gerardi
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Fax: 781-972-5470
Email: jgerardi@healthtech.com

Companies L-Z
Carol Dinerstein
Director, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5471
Fax: 781-972-5470
Email: dinerstein@healthtech.com